Search

everythinglearnresearchcommunity

for

Search:↓

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Treat pediatric skin issues with accurate diagnosis, multidisciplinary team, and various treatment options.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

The document concludes that more research is needed to confirm if COVID-19 vaccines cause a type of hair loss called alopecia areata.

Non-Kuwaitis with COVID-19 had higher chances of severe outcomes than Kuwaitis.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

A man developed neurological issues from SARS-CoV-2 without severe breathing problems, worsening to death.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

AGA linked to worse COVID-19 outcomes in men.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

COVID-19 infection may cause hair loss.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Long COVID causes lasting symptoms and needs ongoing care.